Concepedia

Barbara G. Lubejko

BG

17

Publications

1.6K

Citations

14

H-Index

1991

Active since

Affiliations

Johns Hopkins University(Current)

Oncology Nursing Society

Johns Hopkins Hospital

National Institutes of Health

Johns Hopkins Medicine

Barbara G. Lubejko is an author at Johns Hopkins University specializing in medicine, pharmacology, and oncology.

Top concepts

Publications per year

1991–2019

17

Publications

17

Sequences of taxol and cisplatin: a phase I and pharmacologic study.

Eric K. Rowinsky, Mark R. Gilbert, William P. McGuire et al. · Journal of Clinical Oncology · 1991 · 431 citations

, , +15

Phase I and pharmacologic study of topotecan: a novel topoisomerase I inhibitor.

Eric K. Rowinsky, L B Grochow, Carolyn B. Hendricks et al. · Journal of Clinical Oncology · 1992 · 358 citations

Phase I and pharmacological study of the novel topoisomerase I inhibitor 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin (CPT-11) administered as a ninety-minute infusion every 3 weeks.

Eric K. Rowinsky, L B Grochow, D S Ettinger et al. · PubMed · 1994 · 195 citations

, , +16

Phase I and pharmacologic study of paclitaxel and cisplatin with granulocyte colony-stimulating factor: neuromuscular toxicity is dose-limiting.

Eric K. Rowinsky, Vinay Chaudhry, Arlene A. Forastiere et al. · Journal of Clinical Oncology · 1993 · 193 citations

Phase I and Pharmacologic Studies of Topotecan in Patients With Impaired Hepatic Function

Séamus O’Reilly, Eric K. Rowinsky, William J. Slichenmyer et al. · JNCI Journal of the National Cancer Institute · 1996 · 74 citations · Full text

Rows per page

1–5 of 17